29174 Federal Register / Vol. 63, No. 102 /Thursday, May 28, 1998 / Proposed Rules

List of Subjects in 17 CFR Part 230

Reporting and recordkeeping

requirements, Securities.

Text of Rule and Form Proposals

For the reasons set out in the

preamble, title 17, chapter II of the Code

of Federal Regulations is proposed to be

amended as follows:

PART 230—GENERAL RULES AND

REGULATIONS, SECURITIES ACT OF

1933

1. The citation for Part 230 continues

to read in part as follows:

Authority: 15 U.S.C. 77b, 77f, 77g, 77h, 77j,

77r, 77s, 77sss, 78c, 78d, 78l, 78m, 78n, 78o,

78w, 78ll(d), 79t, 80a–8, 80a–24, 80a–29,

80a–30, and 80a–37, unless otherwise noted.

* * * * *

§ 230.502 [Amended]

2. By amending the introductory text

of paragraph (d) of § 230.502 by revising

the words ‘‘Except as provided in

§ 230.504(b)(1), securities’’ to read

‘‘Securities’’.

3. By revising § 230.504(b)(1) to read

as follows:

§ 230.504 Exemption for limited offerings

and sales of securities not exceeding

$1,000,000.

* * * * *

(b) Conditions to be met.—(1) General

conditions. To qualify for exemption

under this § 230.504, offers and sales

must satisfy the terms and conditions of

§§ 230.501 and 230.502(a) and (d).

* * * * *

Dated: May 21, 1998.

By the Commission.

Margaret H. McFarland,

Deputy Secretary.

[FR Doc. 98–14024 Filed 5–27–98; 8:45 am]

BILLING CODE 8010–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 809 and 864

[Docket No. 97N–0135]

Medical Devices; Hematology and

Pathology Devices; Reclassification;

Restricted Devices; OTC Test Sample

Collection Systems for Drugs of Abuse

Testing; Public Hearing

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notification of public hearing

on proposed rule.

SUMMARY: The Food and Drug

Administration (FDA) is announcing a

public hearing on a proposed rule to

reclassify over-the-counter (OTC) test

sample collection systems for drugs of

abuse testing. The purpose of the public

hearing is to solicit input on the

proposed rule in addition to comments

being submitted to the docket. The

information obtained at the hearing will

assist FDA in its preparation of a final

rule.

DATES: The public hearing will be held

on June 19, 1998, from 9 a.m. to 5 p.m.

Written notices of participation should

be filed by June 8, 1998. Submit written

comments by July 5, 1998.

ADDRESSES: The public hearing will be

held at the Food and Drug

Administration, 5600 Fishers Lane,

conference rooms D and E, Rockville,

MD 20857. Submit written notices of

participation and written comments to

the Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT:

Steven I. Gutman, Center for Devices

and Radiological Health (HFZ–440),

Food and Drug Administration, 2098

Gaither Rd., Rockville, MD 20850, 301–

594–3084.

SUPPLEMENTARY INFORMATION: In the

Federal Register of March 5, 1998 (63

FR 10792), FDA published a proposed

rule to reclassify OTC test sample

collection systems for drugs of abuse

testing. FDA has determined that a

public hearing on the proposed rule is

warranted. The hearing will be directed

by William B. Schultz, Deputy

Commissioner for Policy, FDA. To the

extent possible, oral testimony should

address the issues identified in the

proposed rule (63 FR 10792). The

procedures governing the hearing are

those applicable to a public hearing

before the Commissioner of Food and

Drugs under 21 CFR part 15.

Interested persons who wish to

participate may, on or before June 8,

1998, submit a notice of participation to

the Dockets Management Branch

(address above). All notices submitted

should be identified with the docket

number found in brackets in the

heading of this document and should

contain the name, address, telephone

number, business affiliation of the

person requesting to make a

presentation, a brief summary of the

presentation, and the approximate time

requested for the presentation.

Individuals or groups having similar

interests are requested to consolidate

their comments and present them

through a single representative. FDA

will allocate the time available for the

hearing among the persons who

properly file a notice of appearance.

After reviewing the notice of

participation and accompanying

information, FDA will schedule each

appearance and notify each participant

by mail or telephone of the time allotted

to the person and the approximate time

the person’s presentation is scheduled

to begin. FDA may require joint

presentations by persons with common

interests. The schedule of the public

hearing will be available at the hearing

and it will be placed on file in the

Dockets Management Branch following

the hearing.

The administrative record of the

proposed regulation will be open for 15

days after the hearing to allow

comments on matters raised at the

hearing. Persons who wish to provide

additional materials for consideration

are to file these materials with the

Dockets Management Branch (address

above) during that period.

The hearing is informal, and the rules

of evidence do not apply. No participant

may interrupt the presentation of

another participant. Only the presiding

officers and panel members may

question any person during or at the

conclusion of their presentation.

Dated: May 20, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 98–14048 Filed 5–27–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF THE INTERIOR

Office of Surface Mining Reclamation

and Enforcement

30 CFR Part 936

[SPATS No. OK–022–FOR]

Oklahoma Regulatory Program

AGENCY: Office of Surface Mining

Reclamation and Enforcement (OSM),

Interior.

ACTION: Proposed Rule; reopening and

extension of public comment period on

proposed amendment.

SUMMARY: OSM is announcing receipt of

revisions and additional explanatory

information pertaining to a previously

proposed amendment to the Oklahoma

regulatory program (hereinafter referred

to as the ‘‘Oklahoma program’’) under

the Surface Mining Control and

Reclamation Act of 1977 (SMCRA). The

revisions and additional explanatory

information pertain to normal